Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_assertion type Assertion NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_head.
- NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_assertion description "[Amounts of PGE1, PGE2, and PGF(2alpha), known substrates of 15-PGDH, were markedly increased whereas levels of 13,14-dihydro-15-keto-PGE2, a catabolic product of PGE2, were markedly reduced in NSCLC compared with normal lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_provenance.
- NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_assertion evidence source_evidence_literature NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_provenance.
- NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_assertion SIO_000772 19138967 NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_provenance.
- NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_assertion wasDerivedFrom befree-2016 NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_provenance.
- NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_assertion wasGeneratedBy ECO_0000203 NP713574.RAlaHWEcHq4fRFUA8QRynwl6i_8VRXe8F5swZ2ssky44I130_provenance.